Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.

about

Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.

Item

http://www.wikidata.org/entity/Q44413505

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.

@en

Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.

@nl

type

Item

label

Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.

@en

Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.

@nl

prefLabel

Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.

@en

Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.

@nl

P1476

Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.

@en

P2093

Adrian Sculptoreanu

http://www.w3.org/2001/XMLSchema#string

Daya R Varma

http://www.w3.org/2001/XMLSchema#string

Mohamed Chahine

http://www.w3.org/2001/XMLSchema#string

P2860

Modulating L-type calcium current affects discontinuous cardiac action potential conduction.

Overexpression of Gs alpha protein in the hearts of transgenic mice

Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell.

Modulation of calcium channels in arterial smooth muscle cells by dihydropyridine enantiomers

Voltage-dependent potentiation of the activity of cardiac L-type calcium channel alpha 1 subunits due to phosphorylation by cAMP-dependent protein kinase

Alterations of beta-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure.

Ion channel modulators as potential positive inotropic compound for treatment of heart failure.

G proteins in cardiovascular function and dysfunction.

Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use.

Calcium channel antagonists in the management of anginal syndromes: changing concepts in relation to the role of coronary vasospasm.

P304

135-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1139/Y02-161

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10790458

http://www.w3.org/2001/XMLSchema#string

P698

12710527

http://www.w3.org/2001/XMLSchema#string